FIN.8:4.4 - Value a nontraded strategy on stated grounds

A factory expansion or operating switch usually cannot be bought and sold in the same way as a traded underlying. A market proxy may hedge some exposure while leaving residual risk. Explain what the available trades span and what valuation treatment covers the remainder. A calculated risk-neutral weight from an untraded scenario pair alone does not establish a unique no-arbitrage price.

With supported real-world probabilities, value the contingent strategy using a justified treatment of its risk and the relevant decision perspective. FIN.5 explains matching cash and risk representations. The underlying project’s constant WACC is not automatically appropriate: exercising only in favorable conditions changes the payoff’s exposure, and successive decisions can change it again. Expected cash, certainty equivalents and market pricing weights are different representations and must not be mixed halfway through the tree.

If the basis supports only state-dependent exercise choices or conditional values, return that useful result. Show what remains to establish today’s amount worth paying. Supported bounds can sometimes settle the purchase decision: if even an upper bound on incremental flexibility is below its unavoidable cost, that cost cannot be justified on this basis. A claimed bound itself needs grounds; an optimistic scenario is not automatically an upper bound.

Compare the strategy with the best available fixed commitment and with declining where that is possible. Deduct obtaining and preserving the choice once. The value gained from flexibility is the difference between otherwise comparable strategies, not the entire favorable-state project value. A positive gross option value can coexist with an unattractive purchase price. Include actual exercise funding through FIN.2 and obtainable terms through FIN.10–12; the right can be valuable while the holder cannot presently finance its use.